Investigation of new candidate genes in retinoblastoma using the TruSight One "clinical exome" gene panel.

This study might be an important report on emphazing the mutational status of other genes in patients without RB1 gene mutations and having high risk for developing Rb. The study also indicates the interaction between the retinoic acid pathway and Rb oncogenesis for the first time.